Astellas Pharma (Astellas Pharma) Operating Cash Flow per Share : $0.86 (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Operating Cash Flow per Share?

Astellas Pharma's operating cash flow per share for the three months ended in Dec. 2023 was $0.20. Astellas Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.86.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Astellas Pharma was -16.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Astellas Pharma's Operating Cash Flow per Share or its related term are showing as below:

ALPMY' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -39 Med: 12.3 Max: 65.6
Current: 15

During the past 13 years, Astellas Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 65.60% per year. The lowest was -39.00% per year. And the median was 12.30% per year.

ALPMY's 3-Year OCF Growth Rate is ranked better than
59.11% of 807 companies
in the Drug Manufacturers industry
Industry Median: 8.2 vs ALPMY: 15.00

Astellas Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Astellas Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Operating Cash Flow per Share Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.20

1.10

1.52

1.17

1.34

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.29	0.47	0.05	0.14	0.20

Competitive Comparison of Astellas Pharma's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Astellas Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Price-to-Operating-Cash-Flow falls into.

Astellas Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Astellas Pharma's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	2452.166	/	1825.061
	=	1.34

Astellas Pharma's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	357.088	/	1800.620
	=	0.20

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86

Astellas Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.